Author: Fatima Jabri

We are thrilled to announce the first launch of SIROS™-Sirtex’s innovative New Dose Administration System in Oman. This milestone was achieved in collaboration with our esteemed client, Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC-UMC) in Muscat, under the visionary leadership of Dr. Rashid Al Sukaiti. Notably, SQCCCRC has become the first public hospital in the GCC region to implement this cutting-edge system for the delivery of Y-90 therapy, marking a significant advancement in cancer care.

The SIROS™ Delivery System offers an intuitive, visual, and adaptable solution for physicians to administer SIR-Spheres to liver cancer patients. Its easy-to-use design along with the controlled administration provides the physicians confidence in the Y-90 delivery.

We would like to extend our heartfelt gratitude to Dr. Rashid Al Sukaiti, Dr. Khulood Al Riyami and their dedicated teams, our Sales team and our partner Sirtex for their tireless efforts in making this project a reality. Together, we are committed to advancing healthcare technology for a brighter future!

Key features of SIROS system include:

• Visual: Visually controlled administration enables precision.
• Intuitive: Intuitive design for easy set-up, fluid administration and quick disposal.
• Versatility: Enhanced control allows for more options to tailor sphere delivery.

At Zahrawi Group, we believe in harnessing advanced technology to advance the field of oncology and provide the best possible solutions to our healthcare partners. This launch represents our commitment to supporting patients and practitioners in the journey towards better health.

Our commitment to improving patient care drives us to continually push the boundaries of medical technology. We believe this new system will revolutionize the way liver radioembolization is performed, ultimately leading to better patient outcomes.

Zahrawi Group proudly participated in the International Federation of Sports Medicine (FIMS 2024) World Congress of Sports Medicine at the Dubai World Trade Centre (DWTC), UAE. This prestigious event marked FIMS’s debut in Dubai, offering a unique platform to advance sports medicine.

FIMS serves as a global hub for advancing research and innovation in sports medicine. Its mission is to safeguard the physical and mental well-being of individuals engaged in sports and exercise, while helping athletes reach their full potential by optimizing their genetics, health, nutrition, and access to world-class healthcare and training.

The FIMS 2024 Congress brought together international, regional, and national experts to showcase the latest advancements in the field. Featuring a comprehensive scientific program, attendees gained valuable insights, explored emerging trends, and engaged in impactful collaborations.

Zahrawi Group’s Physiotherapy team proudly showcased a wide range of advanced equipment and technologies from our distinguished partners. These included cutting-edge solutions from Spine Care, Excio, EMS, LymphaTouch, Zamar, RenuVadisc, Hocoma, Biodex, Restorative Therapies, Gymna, INDIBA, and K-Laser. These technologies are instrumental in advancing physiotherapy by enhancing rehabilitation effectiveness, accelerating recovery times, and improving overall patient outcomes, reflecting our ongoing commitment to offering the most advanced and impactful physiotherapy solutions available.

By offering access to innovative solutions, we aim to drive patient recovery and improve quality of life. This collaboration reinforces our vision of promoting healthcare excellence and delivering transformative solutions that enhance well-being across the region.